Generated by GPT-5-mini| Duān Qíruì | |
|---|---|
| Name | Duān Qíruì |
| Native name | 段齊瑞 |
| Birth date | c. 1980s |
| Birth place | Kunming, Yunnan |
| Fields | Virology; Immunology; Epidemiology |
| Workplaces | Tsinghua University; Peking Union Medical College; Chinese Center for Disease Control and Prevention |
| Alma mater | Peking University; Harvard T.H. Chan School of Public Health |
| Known for | Viral pathogenesis; vaccine design; pandemic preparedness |
| Awards | TWAS Prize; Ho Leung Ho Lee Prize |
Duān Qíruì is a Chinese virologist and immunologist noted for work on viral pathogenesis, vaccine platforms, and pandemic preparedness. Her research spans molecular virology, antigen design, and translational vaccine development, with collaborations across Tsinghua University, Peking University, Harvard University, and the World Health Organization. Duān has contributed to rapid response strategies during epidemic events and served on advisory panels for national and international health institutions.
Duān was born in Kunming, Yunnan, and grew up amid regional biodiversity that influenced an early interest in infectious agents and public health, leading her to pursue undergraduate studies at Peking University where she studied molecular biology under mentors linked to the Chinese Academy of Sciences network; she subsequently completed doctoral studies at Harvard T.H. Chan School of Public Health focusing on host–pathogen interactions, and undertook postdoctoral training at Johns Hopkins University and a visiting fellowship at Rockefeller University. During training she worked with investigators associated with the National Institutes of Health, the Wellcome Trust, and the Max Planck Society, and participated in workshops hosted by the Bill & Melinda Gates Foundation and the Carnegie Endowment for International Peace on global health security.
Duān's early faculty appointment was at Peking Union Medical College, where she directed a laboratory integrating structural biology, virology, and translational immunology; later she joined Tsinghua University as a professor and established a translational vaccine center that partnered with the Chinese Center for Disease Control and Prevention and industry partners such as Sinovac and CanSino Biologics for platform development. She has served on advisory committees for the National Health Commission (PRC), consultative panels for the World Health Organization, and expert working groups convened by the United Nations and the Gavi, the Vaccine Alliance. Duān has taught courses linked to programs at Fudan University, supervised doctoral candidates with links to Zhejiang University and Shanghai Jiao Tong University, and co-led multi-institution consortia including collaborators from Imperial College London, University of Oxford, and McMaster University.
Duān's laboratory made seminal contributions to antigen structure-based vaccine design, publishing work that elucidated mechanisms of neutralization for emerging coronaviruses and influenza A viruses, and describing epitope-focused immunogen constructs informed by cryo-electron microscopy studies at facilities including European Molecular Biology Laboratory and Cold Spring Harbor Laboratory. Her publications in journals such as Nature, Science, Cell, The Lancet, and Nature Medicine detail engineered nanoparticle platforms, broadly neutralizing antibody mapping, and correlates of protection assessed in nonhuman primate models often conducted in collaboration with the Yunnan Institute of Primate Research and the Harbin Veterinary Research Institute. Duān contributed to rapid assay development during outbreak responses, co-authoring method papers that integrated next-generation sequencing pipelines from Illumina and antigen reporter systems developed with partners at Broad Institute. She has been a senior author on systematic reviews and policy-relevant commentaries co-published with experts from the Centers for Disease Control and Prevention (United States), the European Centre for Disease Prevention and Control, and the Africa Centres for Disease Control and Prevention about vaccine allocation, variant surveillance, and modular manufacturing.
Duān's honors include the TWAS Prize for medical sciences, the Ho Leung Ho Lee Prize for technological innovation, and an early-career award from the International Union of Microbiological Societies. She was named in lists compiled by Nature and Science recognizing influential researchers and served as a keynote speaker at conferences such as the Cold Spring Harbor Laboratory meetings, the American Society for Virology annual conference, and the Gordon Research Conferences. National recognition included appointment to innovation forums convened by the Ministry of Science and Technology (PRC) and participation in the Young Scientists Forum of the World Economic Forum.
Duān maintains active collaboration networks across Asia, Europe, Africa, and the Americas, mentoring cohorts of researchers who hold positions at institutions including Tsinghua University, Peking University, Imperial College London, and the University of Cape Town. Outside the laboratory she has engaged with science communication initiatives organized by the Royal Society and the China Association for Science and Technology and contributed to capacity-building programs funded by the Asian Development Bank and the United States Agency for International Development. Her legacy includes strengthened translational pipelines for vaccine candidates, protocols for rapid laboratory response during epidemics adopted by public health agencies such as the National Health Commission (PRC) and the World Health Organization, and a generation of interdisciplinary scientists trained at institutions spanning the Chinese Academy of Sciences network and international partner universities.
Category:Chinese virologists Category:Chinese immunologists